Drugs / Myatro
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05803863 | Apr 2023 → Dec 2025 | myopia | University of Medicine and Pharmacy at Ho Chi Minh City | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Myatro | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05803863 ↗ |
| Route | Topical | “Prescribing one 0,01% Myatro (Atropine) drop/eye/night , in 12 months” NCT05803863 ↗ |